S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Cancer-related Problem/Condition, Head and Neck Cancer, Pain

In brief

RATIONALE: Glutamine may be effective in decreasing side effects, such as inflammation of the mouth and throat, caused by radiation therapy. The effectiveness of glutamine for mucositis is not yet known. PURPOSE: Randomized phase III trial to determine the effectiveness of glutamine in treating patients who develop mucositis following radiation therapy for newly diagnosed cancer of the mouth or throat.

Key facts

Study ID
NCT00006994
Run by
SWOG Cancer Research Network
People needed
23
Starts
2001-11-01
Expected to finish
2006-04-01
Last updated by the study team
2015-11-18

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.